This cartoon illustrates the various issues facing individuals across the U.S. who are vaccinated against COVID-19 verus those…
On Sept. 29, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) published positive detailed results…
On Sept. 29, 2021, VBI Vaccines announced positive results from multiple preclinical studies against several COVID-19 variants of…
On Sept. 29, 2021, Roche confirmed positive data from the phase II/III 2066 study, investigating Ronapreveﾙ (casirivimab and…
On Sept. 29, 2021, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
On Sept. 29, 2021, Colossal, a de-extinction company that is combining the science of genetics with the business…
On Sept. 29, 2021, Pfizer and BioNTech positive top-line results from a Phase 3 study (B7471004) evaluating the…
On Sept. 28, 2021, the National Institute of Allergy and Infectious Diseases announced it had awarded approximately $36.3…
On Sept. 28, 2021, the University of Arizona has been awarded a five-year $60 million grant from the…
On Sept. 28, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
On Sept. 28, 2021, the University of Missouri researcher Kamlendra Singh led a team that analyzed protein sequences…
On Sept. 28, 2021, Quest Diagnostics reported that one in two (50.5%) American children under six years of…
On Sept. 28, 2021, Soligenix announced publication of pre-clinical immunogenicity studies for CiVax (heat stable COVID-19 vaccine program)…
On Sept. 27, 2021, Pfizer announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for…
On Sept. 27, 2021, Pfizer announced that the first participants have been dosed in a Phase 1 clinical…
On Sept. 24, 2021, Moderna announced a supply agreement with the government of Peru for 20 million doses…
On Sept. 24, 2021, the U.S. Department of Agriculture’s (USDA) announced confirmation of SARS-CoV-2 in a ferret in…
On Sept. 23, 2021, Novavax announced publication of complete results from a pivotal Phase 3 clinical trial of…
On Sept. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has authorized…
On Sept. 23, 2021, Tonix Pharmaceuticals announced it had expanded its research collaboration with Columbia University. The research…
On Sept. 23, 2021, OraSure Technologies and the Biomedical Advanced Research Development Authority (BARDA) announced up to $13.6…
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
On Sept. 23, 2021, Novavax with its partner, Serum Institute of India, announced a regulatory submission to the…
On Sept. 22, 2021, the Breakthrough Prize Foundation and its founding sponsors announced the 2022 winners of the…
On Sept. 22, 2021, Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates,…
On Sept. 22, 2021, Gilead Sciences announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to…
On Sept. 22, 2021, Pfizer and BioNTech announced plans to expand their agreement with the U.S. government by…
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS (Comisión Federal para la…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…